rs10849448 — LTBR

Regulatory variant in the lymphotoxin beta receptor gene associated with increased susceptibility to recurrent throat infections and tonsillectomy

See your personal result for LTBR

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

LTBR — The Gateway Receptor for Secondary Lymphoid Organ Defense

Your tonsils are not just an annoyance — they are the front-line training grounds of your immune system, strategically positioned at the gateway between the outside world and your body. Lymphotoxin beta receptor (LTBR)11 Lymphotoxin beta receptor (LTBR)
A member of the TNF receptor superfamily, LTBR binds lymphotoxin-α₁β₂ and LIGHT to activate the non-canonical NF-κB pathway is the master organizer of these structures. Without robust LTBR signaling, the architecture of lymph nodes, Peyer's patches, and tonsillar tissue cannot fully develop or maintain itself — leaving mucosal immune defense poorly organized and less effective. The rs10849448 variant sits in the regulatory 5' UTR region of LTBR, where it likely influences how much receptor protein the gene produces.

The Mechanism

LTBR signaling drives the development and maintenance of secondary lymphoid organs (SLOs) — the lymph nodes, spleen, tonsils, and Peyer's patches that intercept pathogens before they enter the bloodstream. The receptor binds two ligands: lymphotoxin-α₁β₂ (a complex of lymphotoxin-α and lymphotoxin-β produced by lymphocytes) and LIGHT (also called TNFSF14). When these ligands engage LTBR, they activate the non-canonical NF-κB pathway22 non-canonical NF-κB pathway
This alternative NF-κB signaling arm drives the production of homeostatic chemokines (CXCL13, CCL19, CCL21) that organize B and T cell zones inside lymphoid organs, enabling the formation of germinal centers33 germinal centers
The specialized structures inside lymph nodes where B cells undergo affinity maturation and class-switching to produce high-quality antibodies.

The rs10849448 A>G polymorphism falls in the 5' UTR of LTBR — a region that controls transcript stability and translational efficiency. The risk A allele is associated with altered LTBR expression.

The Evidence

The A allele's role in infection susceptibility was established in a landmark genome-wide association study of 23 common infections44 genome-wide association study of 23 common infections
Tian et al. analyzed 200,000+ individuals of European ancestry through 23andMe, examining phenotypes from tonsillectomy to tuberculosis that identified rs10849448 as the strongest non-HLA genome-wide signal for tonsillectomy (OR=1.13, P=2×10⁻³⁵). The same A allele was previously identified in a dense genotyping study of juvenile idiopathic arthritis55 dense genotyping study of juvenile idiopathic arthritis
Hinks et al. used the Immunochip array to study 2,816 JIA cases and 13,056 controls showing association with oligoarticular and RF-negative JIA (OR=1.24, P=5×10⁻⁹) — forms of JIA with prominent involvement of mucosal immune dysregulation.

Practical Actions

For A allele carriers, the primary implication is heightened vulnerability to recurrent upper respiratory and throat infections. AA carriers were historically more likely to undergo tonsillectomy: recurrent tonsillitis severe enough to warrant surgery correlates with this genotype at a population level.

The secondary implication — the JIA association — suggests a broader tendency for mucosal immune dysregulation that can tip into autoimmune reactivity in certain environments. Carriers do not inevitably develop JIA, but the shared genetic architecture between recurrent infections and this autoimmune form highlights that the same LTBR pathway controls the balance between defensive responses and aberrant self-reactivity.

Interactions

LTBR works in concert with other TNF superfamily receptors and their shared ligands. The TNFSF13B gene (encoding BAFF/BLyS) and TNFRSF13B (TACI, the BAFF receptor) are key pathway partners — both regulate B cell survival within the germinal centers that LTBR helps organize. Genetic variation in the TNF/LT locus on chromosome 6p21 (near HLA) also modulates lymphoid architecture, and the tonsillectomy GWAS found multiple independent HLA-region signals alongside rs10849448, suggesting additive risk when LTBR dysregulation combines with HLA-mediated immune recognition changes.

Genotype Interpretations

What each possible genotype means for this variant.

GG Normal

Standard LTBR expression with typical mucosal immune defense

You carry two copies of the G allele, the common form of this variant found in roughly 68% of people globally. Your LTBR gene likely produces receptor at normal levels, supporting well-organized lymphoid tissue architecture in tonsils, lymph nodes, and gut-associated lymphoid tissue. You have typical baseline susceptibility to recurrent throat infections.

AG Intermediate

One risk copy — modestly increased susceptibility to throat and upper respiratory infections

The A allele affects the 5' UTR of LTBR, a region governing how efficiently the gene is translated into protein.

The JIA association (OR=1.24 in Immunochip data) is relevant context: the same LTBR pathway that protects against infections when properly calibrated can contribute to autoimmune-adjacent phenotypes when disrupted. AG carriers should be alert to unusually frequent or prolonged throat infections and discuss patterns with a physician if these recur.

AA High Risk

Two risk copies — meaningfully increased susceptibility to recurrent throat infections

The JIA association (OR=1.24 for oligoarticular RF-negative JIA) is most relevant for individuals with a personal or family history of childhood arthritis — the LTBR pathway is implicated in the breakdown of mucosal immune tolerance that precedes autoimmune joint involvement in susceptible individuals.